4th Quarter - Report

MUSCULAR DYSTROPHY ASSOCIATION, INC. for MUSCULAR DYSTROPHY ASSOCIATION, INC.

Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Insurance INS

Advocated for passage of the ALS Disability Insurance Act (HR 1407, S 578) which would eliminate the five month waiting period for individuals with ALS to obtain Social Security disability insurance.

LobbyistCovered position, as disclosed
MARC GOTTSCHALK New —
BRITTANY JOHNSON HERNANDEZ —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Office of Management & Budget (OMB); Federal Aviation Administration (FAA); Transportation, Dept of (DOT)

Bills named: H.R. 1407 (116th)

Labor Issues/Antitrust/Workplace LBR

Advocated for passage of the Disability Employment Incentive Act (S.255, HR 3992) to create tax credits to incentivize the hiring and retaining of individuals living with disabilities.

LobbyistCovered position, as disclosed
MARC GOTTSCHALK New —
BRITTANY JOHNSON HERNANDEZ —

Contacted: Transportation, Dept of (DOT); Federal Aviation Administration (FAA); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institutes of Health (NIH)

Bills named: S. 255 (116th), H.R. 3992 (116th)

Medical/Disease Research/Clinical Labs MED

Advocated in favor of robust appropriations funding for the National Institutes of Health, the Food and Drug Administration, the Health Resources and Services Administration, and the Centers for Disease Control and Prevention.

LobbyistCovered position, as disclosed
MARC GOTTSCHALK New —
BRITTANY JOHNSON HERNANDEZ —
PAUL MELMEYER —

Contacted: Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; Natl Institutes of Health (NIH); Transportation, Dept of (DOT); Federal Aviation Administration (FAA)

Health Issues HCR

Health care issues affecting individuals with neuromuscular disease including therapy development, newborn screening, screening and diagnosis, adequate insurance coverage, and access to care. Advocated for passage of H.R. 4393, the Advancing Access to Precision Medicine Act, provide for a State option under the State Medicaid plan to provide DNA sequencing clinical services for certain children. Advocated for passage of H.R. 3235, the Access to Genetic Counselor Services Act of 2019, to provide for expanded coverage of services provided by genetic counselors. Advocated for the passage of the Newborn Screening Saves Lives Reauthorization Act, H.R. 2507 / S. 2158, to encourage investment in the national newborn screening program in order to detect more neuromuscular conditions early to speed appropriate interventions for patients. Advocated for increased funding for National Institutes of Health, Food and Drug Administration, Health Resources and Services Administration, and other health agencies that conduct research on neuromuscular disease and provide services to those with these conditions. Advocated for adequate, affordable, accessible health coverage for individuals with neuromuscular conditions. Advocated for passage of H.R. 986, the Protecting Americans with Preexisting Conditions Act of 2019, which would require the Administration to rescind its Section 1332 State Relief and Empowerment Waivers Guidance, released on October 22, 2018 (1332 guidance). The guidance would allow states to let individuals use advanced premium tax credits to purchase non-compliant short-term, limited duration insurance plans-which could further draw younger, healthier people out of the risk pool for comprehensive insurance and drive up premiums for those who need comprehensive coverage, such as individuals with neuromuscular conditions. Also advocated for the passage of H.R. 1010, legislation to provide that the rule entitled Short-Term, Limited Duration Insurance shall have no force or effect. Issues related to surprise medical billing, including HR 3630, the No Surprises Act; S 1895, the Lower Health Care Costs Act; S 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019. Advocated for maintaining strong incentives for rare disease drug development included within the Orphan Drug Act (PL 97-414) Advocated for the continuance of the Rare Pediatric Disease Priority Review Voucher Program within the context of the Creating Hope Reauthorization Act (H.R.4439)

LobbyistCovered position, as disclosed
MARC GOTTSCHALK New —
BRITTANY JOHNSON HERNANDEZ —
PAUL MELMEYER —

Contacted: Transportation, Dept of (DOT); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Federal Aviation Administration (FAA); SENATE

Bills named: H.R. 986 (116th), H.R. 3235 (116th), H.R. 3630 (116th), H.R. 4393 (116th), S. 2158 (116th), H.R. 2507 (116th), H.R. 1010 (116th), H.R. 4439 (116th)

Medicare/Medicaid MMM

Advocated for adequate, affordable, accessible health coverage for individuals with neuromuscular conditions. Cited opposition to the expansion of Section 1115 demonstration waivers that would create substantial barriers to care for patients and families who enroll in Medicaid.

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —

Contacted: Centers For Medicare and Medicaid Services (CMS); Federal Aviation Administration (FAA); Food & Drug Administration (FDA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE; Transportation, Dept of (DOT)

Budget/Appropriations BUD

Advocated in favor of robust appropriations funding for the National Institutes of Health, the Food and Drug Administration, the Health Resources and Services Administration, and the Centers for Disease Control and Prevention. Advocated for ongoing funding of the national newborn screening program.

LobbyistCovered position, as disclosed
BRITTANY JOHNSON HERNANDEZ —
PAUL MELMEYER —

Contacted: Office of Management & Budget (OMB); SENATE; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Transportation, Dept of (DOT); HOUSE OF REPRESENTATIVES; Federal Aviation Administration (FAA)

Aviation/Airlines/Airports AVI

Advocated for access to air travel for individuals with neuromuscular conditions by advocating for ongoing implementation of the Air Carrier Access Act (ACAA) and the Federal Aviation Administration Reauthorization Act of 2017. Advocated for passage of the Air Carrier Access Amendments Act (S. 669, H.R. 1549).

LobbyistCovered position, as disclosed
MARC GOTTSCHALK New —
BRITTANY JOHNSON HERNANDEZ —
PAUL MELMEYER —

Contacted: Transportation, Dept of (DOT); Federal Aviation Administration (FAA); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); SENATE; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1549 (116th), S. 669 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.